drugset / Trial / NCT06430502
Clinical Efficacy of Tumour Treatment Vaccine (TTV) Combined With PD-1 in the Treatment of Relapsed Refractory Advanced Solid Tumours
NaSingle-groupOpen-labelTreatment
Summary
This study is intended to investigate the clinical efficacy of TTV vaccine combined with PD-1/PD-L1 inhibitor in the treatment of relapsed and refractory advanced solid tumours from a clinical perspective.
Timeline
- Start
- 2024-05-07
- Primary completion
- 2027-06-01
- Completion
- 2027-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tumor Treatment Vaccine | Vaccine | 1 ml | Subcutaneous |
| Subject | Tumor Treatment Vaccine | Vaccine | 2.5 ml | Subcutaneous |
| Subject | Tumor Treatment Vaccine | Vaccine | 4 ml | Subcutaneous |